Aligos Therapeutics, Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2019 | $-13.02 | $-15.97 |
| FY2020 | $-5.44 | $-11.28 |
| FY2021 | $-1.61 | $-8.14 |
| FY2022 | $-1.13 | $-6.41 |
| FY2023 | $-17.10 | $-8.65 |
| FY2024 | $-20.94 | $-10.70 |
| FY2025 | $-2.45 | $-9.52 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2019 | $-13.02 | $-15.97 |
| FY2020 | $-5.44 | $-11.28 |
| FY2021 | $-1.61 | $-8.14 |
| FY2022 | $-1.13 | $-6.41 |
| FY2023 | $-17.10 | $-8.65 |
| FY2024 | $-20.94 | $-10.70 |
| FY2025 | $-2.45 | $-9.52 |